Since June 2020 the FDA has approved 6 new blood cancer treatments and expanded the use of an already available treatment. Sadly none are approved for use in Australia yet. This highlights how important it is that we continue to fund research through clinical trials to provide access to next generation treatments ahead of Australian … Continued
Dr Michael Dickinson is the Lead of the Aggressive Lymphoma disease group within Clinical Haematology at Peter MacCallum Cancer Centre and Royal Melbourne Hospital. Michael has been instrumental in treating patients with chimeric antigen receptor T (CAR-T) cell therapy nationally. As Snowdome supported Michael for several years as the Peter MacCallum Cancer Centre Clinician Researcher … Continued
Four years ago, if you had a blood cancer in Western Australia (WA) and needed access to the latest treatment via a clinical trial, you had no alternative other than flying to Melbourne or Sydney, every other week. This inequality of care in Western Australia led Snowdome to fund Blood Cancer Research WA. The centre … Continued
Chimeric Antigen Receptor (CAR) T cell therapy has been approved in Australia for forms of leukaemia and lymphoma for a while now, but we are still awaiting adequate evidence that CAR-T cell therapy works effectively in myeloma. CAR-T cell therapy genetically modifies T-cells to hunt out and find a protein (CD19) that is found on … Continued
Dr Kylee Maclachlan moved her career and her family to New York City in August last year to help improve outcomes for Australian myeloma patients. Kylee is aiming to establish an ongoing collaboration between the Peter MacCallum Cancer Centre and the Memorial Sloan Kettering Cancer Centre to share clinical trials, treatment protocols and expert knowledge. … Continued
The Australian featured an exclusive story on the remarkable insights provided by genomic testing. To quote Dr Piers Blombery, Head of the Molecular Haematology Laboratory at the Peter MacCallum Cancer Centre,“Every cancer is different and genomics testing such as the ctDNA panel gives clinicians more details about what drives the individual patient’s tumour cells; it … Continued
Prof Prince provides another useful update on the COVID-19 pandemic. This week he discusses the importance of downloading the government COVID app. The difference between a virus and a bacterial infection, your questions surrounding immunity as a blood cancer patient and resuming scheduled SCT. Lastly he touches on the importance donating to the Snowdome Foundation. … Continued
Associate Professor Chan Cheah heads up Blood Cancer Research WA which aims to bring blood cancer clinical trials to patients in Western Australia. The Snowdome Foundation is a very proud supporter of this initiative. He has kindly provided an update on COVID 19 for blood cancer patients. He discusses visits to your doctor, your risk … Continued
Prof Miles Prince provides another update on the coronavirus pandemic. He emphasises the need to maintain social distancing, as on average one person with COVID 19 spreads it to two other people. He discusses the value of using a face mask when we are able to move about in society and again and to get … Continued